Wall Street thinks the $1 billion market CBD could explode to $16 billion by 2025

In the healthcare realm, the analysts noted that on the heels of the recent FDA approval of Epidiolex, more companies could be working on similar products. Canadian marijuana producerCBD products are also gaining a presence in independent pharmacies — the non-Walgreens or CVSs of the world — where they are already selling or have plans to sell CBD oil.

And although large pharmacy chains like CVS are not currently selling CBD, they may do so in the future. The analysts note that the US holding company behind Walgreens, known as the Walgreens Boots Alliance, for example, has indicated that it is monitoring the CBD market.A drug derived from marijuana has become the first to win federal approval, and experts predict an avalanche effect

Lab-grown CBD and THC have gained a lot of recent interest from startups in recent years. The process would use a technique known as synthetic biology or biosynthesis to coax genetically altered organisms like yeast into churning out the marijuana compounds. Doing so, the analysts write, could save manufacturers money and time.with Canadian cannabis company Cronos to make compounds like THC and CBD in a lab.

SamirMustafic20

I hope so since I invested !

Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen

Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.

Wall Street Is Gushing Over Palo Alto Stock After Earnings Crushed EstimatesThe cybersecurity company crushed Wall Street profit expectations and reported fiscal second-quarter adjusted earnings per share of $1.51 versus the $1.22 consensus. It also gave sales guidance for its fiscal-third-quarter above the average analyst projection.
Herkunft: MarketWatch - 🏆 3. / 97 Weiterlesen »